Oscar Health, Inc.

Oscar Health, Inc. has seen a notable increase in its stock price, reflecting strong activity in the healthcare services sector. Despite recent gains, the company faces challenges with negative operating profits and margins, alongside a significant market capitalization and a complex financial landscape characterized by a negative return on equity.

Oscar Health, Inc. experienced a significant one-day performance, outperforming the S&P 500. However, the company reported substantial financial losses, including a low operating profit and negative margins. Mixed technical indicators further complicate its financial outlook as it faces ongoing challenges in the healthcare services sector.

Oscar Health, Inc. has recently revised its evaluation amid changing market conditions. The company's stock price is currently $15.63, reflecting a slight increase. Over the past year, Oscar Health has achieved a 26.56% return, contrasting with the S&P 500's 33.47%. Its performance shows significant volatility over different time frames.

Oscar Health, Inc. has seen a notable rise in its stock performance, achieving a significant weekly increase. Despite facing challenges such as negative operating profits and a history of losses, the company's recent activity reflects resilience in a difficult market environment, attracting investor attention.

Oscar Health, Inc. has experienced a significant stock performance increase, outperforming the S&P 500. Despite this, the company continues to face challenges with negative operating profits for nine quarters and a high debt-to-equity ratio. Its market capitalization is around USD 3,958 million, with notable profit growth over the past year.

Oscar Health, Inc. has reached a new 52-week low, reflecting a challenging year with a notable decline in performance. The company, with a market capitalization of approximately USD 3,958 million, reported significant losses and negative financial metrics, indicating ongoing difficulties in the healthcare sector.

Oscar Health, Inc. has seen a notable rise in its stock today, contrasting with a slight decline in the S&P 500. While the company has experienced significant short-term gains, it faces longer-term challenges, including negative operating profits and a low return on equity, amidst a volatile market environment.

Oscar Health, Inc. saw a significant stock increase today, contrasting with the modest rise of the S&P 500. While the company has gained year-to-date, its longer-term performance shows challenges, including a decline over the past month and a negative one-year return. Oscar Health operates in the healthcare services sector.

Oscar Health, Inc. has seen a significant rise in its stock today, reaching an intraday high and contrasting with a decline in the S&P 500. Year-to-date, the company has outperformed the index, though it has faced challenges over the past year. Its market capitalization stands at USD 5,250 million.

Oscar Health, Inc. achieved a new 52-week high of USD 23.74 on October 7, 2025, reflecting a year-over-year performance of 9.56%. With a market capitalization of USD 5,250 million, the company has a P/E ratio of 32.00 and a price-to-book ratio of 4.53, indicating its valuation dynamics.

Oscar Health, Inc. has recently revised its evaluation, reflecting strong market dynamics. The stock has shown impressive performance, with a year-to-date return of 66% and a three-year return of 369.68%. Technical indicators suggest a generally positive outlook, highlighting the company's resilience in the competitive healthcare services sector.

Oscar Health, Inc. has seen a notable rise in its stock performance, reaching an intraday high and demonstrating significant market activity. While the company has outperformed the S&P 500 in recent weeks and year-to-date, it has faced challenges over the past year, reflecting its financial volatility.

Oscar Health, Inc. saw a notable increase in its stock performance on September 18, 2025, reaching an intraday high of USD 19.17. The company has demonstrated strong short-term gains, significantly outperforming the S&P 500, while facing challenges over the past year. Its market capitalization is USD 5,250 million.